Clinical Trials Directory

Trials / Unknown

UnknownNCT04511481

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
93 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
22 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Platinum-sensitive is an important basis for the treatment of recurrent epithelial ovarian cancer (EOC) without effective methods to predict.We aimed to develop and validate the EOC deep learning system to predict the platinum-sensitive of EOC patients through analysis of enhanced magnetic resonance imaging (MRI) images before initial treatment.Ninety-three EOC patients received platinum-based chemotherapy (\>= 4 cycles) and debulking surgery from Sun Yat-sen Memorial Hospitalin China from January 2011 to January 2020 were enrolled. This deep-learning EOC signature achieved a high predictive power for platinum-sensitive, and the signature based on MRI whole volume is better than that on primary tumor area only.

Conditions

Interventions

TypeNameDescription
OTHERRadiomic AlgorithmDifferent radiomic and machine learning strategies for radiomic features extraction, sorting features and model constriction

Timeline

Start date
2020-04-15
Primary completion
2020-08-03
Completion
2021-01-01
First posted
2020-08-13
Last updated
2020-08-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04511481. Inclusion in this directory is not an endorsement.